Bonraybio Co., Ltd.
Research Bonraybio Co., Ltd. (6955.TW) on Bullrun: market cap TWD 2.83B, P/E 26.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6955.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 2.83B
- P/E26.3
- Financial periodQ2 2026
- RevenueTWD 92.33M
- Net incomeTWD 28.39M
- Free cash flowTWD 8.13M
- Gross margin78.5%
Valuation Snapshot
latest market cap is TWD 2.83B; P/E is 26.3.
Peer valuation comparison
Latest P/E is 26.3x versus a Healthcare sector median of 21.8x (20.7% above).
Latest P/E is 26.3x versus a Taiwan median of 18.67x (40.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.83B | 26.3 | n/a | 1.23 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.23 TWD.
About Bonraybio Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bonraybio Co., Ltd.'s market cap?
Bonraybio Co., Ltd.'s market capitalization is TWD 2.83B.
What is Bonraybio Co., Ltd.'s P/E ratio?
Bonraybio Co., Ltd.'s price-to-earnings (P/E) ratio is 26.3.
What does Bonraybio Co., Ltd. do?
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.